|
Sep 29
|
Is Insmed Incorporated (INSM) the Best Performing Long Term Stock in 2024?
|
|
Sep 26
|
Is Insmed Inc. (INSM) the Best Performing Stock in 2024?
|
|
Jul 31
|
Swelling losses haven't held back gains for Insmed (NASDAQ:INSM) shareholders since they're up 328% over 5 years
|
|
Jul 29
|
Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 29
|
Insmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024
|
|
Jul 25
|
These Signs Show Which Stocks Are Having A Hidden Rally, Says Mark Minervini
|
|
Jul 25
|
Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Jul 16
|
What Makes Insmed Incorporated (INSM) a Prospective Investment?
|
|
Jun 14
|
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
|
|
May 11
|
Insmed Incorporated (NASDAQ:INSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
|
|
May 10
|
Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Insmed Inc (INSM) Reports Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows Amidst Clinical ...
|
|
May 10
|
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
|
|
May 10
|
Insmed First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
|
May 9
|
Insmed (INSM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
May 9
|
Insmed (INSM) Reports Q1 Loss, Lags Revenue Estimates
|
|
May 9
|
Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update
|
|
May 8
|
Should You Buy Insmed (INSM) Ahead of Earnings?
|
|
May 7
|
Will Tango Therapeutics, Inc. (TNGX) Report Negative Q1 Earnings? What You Should Know
|
|
May 7
|
Insmed To Present at the BofA Securities Health Care Conference 2024
|